Veterinary Sciences (Sep 2022)

Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs

  • Erin A. Gibson,
  • Roger E. Goldman,
  • William T. N. Culp

DOI
https://doi.org/10.3390/vetsci9090489
Journal volume & issue
Vol. 9, no. 9
p. 489

Abstract

Read online

Primary hepatic neoplasia is uncommonly reported in dogs. Hepatocellular carcinoma (HCC) is the most frequent neoplasia identified in dogs and considerable effort has been committed towards identifying definitive and palliative treatment options. HCC is well recognized in humans as a sequelae of liver disease such as hepatitis or cirrhosis, while in dogs a similar link has failed to be fully elucidated. Management of HCC in people may be curative or palliative dependent on staging and transplant eligibility. Despite differences in etiology, there is substantial similarity between treatment options for liver neoplasia in human and veterinary medicine. The below summary provides a comparative discussion regarding hepatic neoplasia in dogs and people with a specific focus on HCC. Diagnosis as well as descriptions of the myriad treatment options will be reviewed.

Keywords